Health Plan News logo

Nothing to see here

You seemed to have found a mislinked file, page, or search query with zero results. If you feel that you've reached this page in error, double check the URL and or search string and try again.

Alternatively, a more personalized method of tracking down and searching for content can be found below.

  • February 23rd 2014
    Tags: Healthcare Plan News Comments Off

    Study Finds More Than 20 Million Americans Suffer from Blenophobia Fear of Needles

    More than 15 million American adults and five million children over the age of five suffer from high discomfort or exhibit needle-phobic behavior when faced with getting a blood draw or injection, according to results from a new study, with the overwhelming majority of those studied - 75 percent adults ...
    January 3rd 2014
    Tags: J.P. Morgan Healthcare Conference Comments Off

    Healthcare Companies Set to Present at the 32nd Annual J.P. Morgan Healthcare Conference

    There are several companies who will have their representatives present at the 32nd annual J.P. Morgan Healthcare Conference. J.P. Morgan's 32nd Annual Healthcare Conference will be held January 13-16, 2014 in San Francisco, California. Endo Health Solutions (Nasdaq: ENDP) announced that Rajiv De Silva, President and Chief Executive Officer, will present ...
    October 29th 2013
    Tags: Healthcare Plan News Comments Off

    WebMD Acquires Avado

    WebMD Health Corp. (NASDAQ: WBMD), the leading source of health information, has acquired Avado, Inc., a developer of cloud-based patient relationship management (PRM) tools and technologies that enable better communication between consumers and health care professionals. WebMD's connectivity platform is enabling physicians that use its Medscape mobile app to securely send ...
    October 29th 2013
    Tags: Healthcare Plan News Comments Off

    InspireMD’s MGuard Stent Shows Lower Mortality Rate in STEMI Patients

    InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection stents, recently announced new 12-month results from the MASTER (MGuard for Acute ST Elevation Reperfusion) trial demonstrating that the MGuard outperformed bare metal and drug eluting stents in all-cause mortality in ST segment elevation myocardial infarction ...
    October 10th 2013
    Tags: Pharmaceutical Companies Comments Off

    Morgan & Morgan Investigating Ariad Pharmaceuticals ARIA

    Morgan & Morgan is investigating whether or not Ariad Pharmaceuticals Inc. ("Ariad" or the "Company") (ARIA) and certain of its officers violated the federal securities laws when making statements to investors regarding its experimental drug Iclusig. On October 9, 2013, the Company updated the data from its PACE trial of Iclusig ...


    The archives run deep. Feel free to search older content using topic keywords.